Loading...

Sera Prognostics, Inc.

SERANASDAQ
Healthcare
Medical - Diagnostics & Research
$2.64
$0.26(10.92%)

Sera Prognostics, Inc. (SERA) Financial Performance & Income Statement Overview

Analyze Sera Prognostics, Inc. (SERA) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
-74.84%
74.84%
Operating Income Growth
8.001%
8.001%
Net Income Growth
9.23%
9.23%
Operating Cash Flow Growth
47.81%
47.81%
Operating Margin
-34125.00%
34125.00%
Gross Margin
-209.26%
209.26%
Net Profit Margin
-30306.48%
30306.48%
ROE
-45.86%
45.86%
ROIC
-41.77%
41.77%

Sera Prognostics, Inc. (SERA) Income Statement & Financial Overview

Explore comprehensive income reports for Sera Prognostics, Inc. SERA, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$38000.00$24000.00$29000.00$24000.00
Cost of Revenue$40000.00$32000.00$13000.00$20000.00
Gross Profit-$2000.00-$8000.00$16000.00$4000.00
Gross Profit Ratio-$0.05-$0.33$0.55$0.17
R&D Expenses$3.33M$3.14M$3.50M$4.41M
SG&A Expenses$5.91M$6.28M$5.38M$4.85M
Operating Expenses$9.25M$9.41M$8.88M$9.26M
Total Costs & Expenses$9.29M$9.45M$8.89M$9.28M
Interest Income$0.00$673000.00$733000.00$671000.00
Interest Expense-$4000.00$6000.00$5000.00$8000.00
Depreciation & Amortization$0.00$211000.00$201000.00$208000.00
EBITDA-$9.25M-$8.36M-$7.71M-$8.09M
EBITDA Ratio-$243.42-$348.42-$265.97-$336.96
Operating Income-$9.25M-$9.42M-$8.86M-$9.25M
Operating Income Ratio-$243.42-$392.63-$305.59-$385.54
Other Income/Expenses (Net)$1.06M$844000.00$943000.00$950000.00
Income Before Tax-$8.19M-$8.58M-$7.92M-$8.30M
Income Before Tax Ratio-$215.45-$357.46-$273.07-$345.96
Income Tax Expense$0.00$0.00$0.00$0.00
Net Income-$8.19M-$8.58M-$7.92M-$8.30M
Net Income Ratio-$215.45-$357.46-$273.07-$345.96
EPS-$0.20-$0.25-$0.24-$0.25
Diluted EPS-$0.20-$0.25-$0.24-$0.25
Weighted Avg Shares Outstanding$41.97M$33.94M$33.52M$32.93M
Weighted Avg Shares Outstanding (Diluted)$41.97M$33.94M$33.52M$32.93M

Over the last four quarters, Sera Prognostics, Inc. achieved steady financial progress, growing revenue from $24000.00 in Q2 2024 to $38000.00 in Q1 2025. Gross profit stayed firm with margins at -5% in Q1 2025 versus 17% in Q2 2024. Operating income totaled -$9.25M in Q1 2025, maintaining a -24342% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$9.25M. Net income rose to -$8.19M, with EPS at -$0.20. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;